Methods and compositions relating to ClbP inhibition
Abstract:
The technology described herein is directed to methods and compositions for inhibition of ClbP and the treatment and/or prevention of cancer, e.g., colorectal cancer, a urinary tract cancer, a squamous cell carcinoma, an oral squamous cell carcinoma, or a head-and-neck cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0